Terms: = Bone cancer AND SYK, P43405, 6850, ENSG00000165025
61 results:
1. Self-supervised tumor segmentation and prognosis prediction in osteosarcoma using multiparametric MRI and clinical characteristics.
Zhou Z; Xie P; Dai Z; Wu J
Comput Methods Programs Biomed; 2024 Feb; 244():107974. PubMed ID: 38154327
[TBL] [Abstract] [Full Text] [Related]
2. Co-localization of Fibronectin Receptors LILRB4/gp49B and Integrin on Dendritic Cell Surface.
Takahashi N; Itoi S; Su MT; Endo S; Takai T
Tohoku J Exp Med; 2022 Jun; 257(3):171-180. PubMed ID: 35691913
[TBL] [Abstract] [Full Text] [Related]
3. Hox transcript antisense RNA knockdown inhibits osteosarcoma progression by regulating the phosphoinositide 3-kinase/AKT pathway through the microRNA miR-6888-3p/spleen tyrosine kinase axis.
Wu W; Wang L; Li S
Bioengineered; 2022 Apr; 13(4):9397-9410. PubMed ID: 35435107
[TBL] [Abstract] [Full Text] [Related]
4. American Joint Committee on cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract] [Full Text] [Related]
5. Targeting the ERβ/HER Oncogenic Network in
Almotlak AA; Farooqui M; Soloff AC; Siegfried JM; Stabile LP
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008514
[TBL] [Abstract] [Full Text] [Related]
6. The FcεRI signaling pathway is involved in the pathogenesis of lacrimal gland benign lymphoepithelial lesions as shown by transcriptomic analysis.
Li J; Liu R; Sun M; Wang J; Wang N; Zhang X; Ge X; Ma J
Sci Rep; 2021 Nov; 11(1):21853. PubMed ID: 34750466
[TBL] [Abstract] [Full Text] [Related]
7. miR-96-5p is the tumor suppressor in osteosarcoma via targeting syk.
Wang T; Xu Y; Liu X; Zeng Y; Liu L
Biochem Biophys Res Commun; 2021 Oct; 572():49-56. PubMed ID: 34343834
[TBL] [Abstract] [Full Text] [Related]
8. Spleen tyrosine kinase (syk) inhibitor PRT062607 protects against ovariectomy-induced bone loss and breast cancer-induced bone destruction.
Xie G; Liu W; Lian Z; Xie D; Yuan G; Ye J; Lin Z; Wang W; Zeng J; Shen H; Wang X; Feng H; Cong W; Yao G
Biochem Pharmacol; 2021 Jun; 188():114579. PubMed ID: 33895161
[TBL] [Abstract] [Full Text] [Related]
9. Gain-of-function variants in syk cause immune dysregulation and systemic inflammation in humans and mice.
Wang L; Aschenbrenner D; Zeng Z; Cao X; Mayr D; Mehta M; Capitani M; Warner N; Pan J; Wang L; Li Q; Zuo T; Cohen-Kedar S; Lu J; Ardy RC; Mulder DJ; Dissanayake D; Peng K; Huang Z; Li X; Wang Y; Wang X; Li S; Bullers S; Gammage AN; Warnatz K; Schiefer AI; Krivan G; Goda V; Kahr WHA; Lemaire M; ; Lu CY; Siddiqui I; Surette MG; Kotlarz D; Engelhardt KR; Griffin HR; Rottapel R; Decaluwe H; Laxer RM; Proietti M; Hambleton S; Elcombe S; Guo CH; Grimbacher B; Dotan I; Ng SC; Freeman SA; Snapper SB; Klein C; Boztug K; Huang Y; Li D; Uhlig HH; Muise AM
Nat Genet; 2021 Apr; 53(4):500-510. PubMed ID: 33782605
[TBL] [Abstract] [Full Text] [Related]
10. A Proteomic Approach to Understand the Clinical Significance of Acute Myeloid Leukemia-Derived Extracellular Vesicles Reflecting Essential Characteristics of Leukemia.
Kang KW; Kim H; Hur W; Jung JH; Jeong SJ; Shin H; Seo D; Jeong H; Choi B; Hong S; Kim HK; Choi Y; Park JH; Lee KY; Kim KP; Park Y
Mol Cell Proteomics; 2021; 20():100017. PubMed ID: 33592500
[TBL] [Abstract] [Full Text] [Related]
11. The Mincle/syk/NF-κB Signaling Circuit Is Essential for Maintaining the Protumoral Activities of Tumor-Associated Macrophages.
Li C; Xue VW; Wang QM; Lian GY; Huang XR; Lee TL; To KF; Tang PM; Lan HY
Cancer Immunol Res; 2020 Aug; 8(8):1004-1017. PubMed ID: 32532809
[TBL] [Abstract] [Full Text] [Related]
12. bone dynamics and inflammation: lessons from rare diseases.
Matsumoto Y; Rottapel R
Immunol Med; 2020 Jun; 43(2):61-64. PubMed ID: 31999934
[TBL] [Abstract] [Full Text] [Related]
13. Macrophage syk-PI3Kγ Inhibits Antitumor Immunity: SRX3207, a Novel Dual syk-PI3K Inhibitory Chemotype Relieves Tumor Immunosuppression.
Joshi S; Liu KX; Zulcic M; Singh AR; Skola D; Glass CK; Sanders PD; Sharabi AB; Pham TV; Tamayo P; Shiang D; Dinh HQ; Hedrick CC; Morales GA; Garlich JR; Durden DL
Mol Cancer Ther; 2020 Mar; 19(3):755-764. PubMed ID: 31974273
[TBL] [Abstract] [Full Text] [Related]
14. ST5 Positively Regulates Osteoclastogenesis via Src/syk/calcium Signaling Pathways.
Kim MK; Kim B; Kwon JO; Song MK; Jung S; Lee ZH; Kim HH
Mol Cells; 2019 Nov; 42(11):810-819. PubMed ID: 31707778
[TBL] [Abstract] [Full Text] [Related]
15. Filamin A: key actor in platelet biology.
Rosa JP; Raslova H; Bryckaert M
Blood; 2019 Oct; 134(16):1279-1288. PubMed ID: 31471375
[TBL] [Abstract] [Full Text] [Related]
16. All-Trans Retinoic Acid Impairs Platelet Function and Thrombus Formation and Inhibits Protein Kinase CßI/δ Phosphorylation.
Luo Q; Wei G; Wang X; Xu X; Ju W; Li Z; Gardiner EE; Andrews RK; Zeng L; Xu K; Qiao J
Thromb Haemost; 2019 Oct; 119(10):1655-1664. PubMed ID: 31370073
[TBL] [Abstract] [Full Text] [Related]
17. Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.
Lossos C; Liu Y; Kolb KE; Christie AL; Van Scoyk A; Prakadan SM; Shigemori K; Stevenson KE; Morrow S; Plana OD; Fraser C; Jones KL; Liu H; Pallasch CP; Modiste R; Nguyen QD; Craig JW; Morgan EA; Vega F; Aster JC; Sarosiek KA; Shalek AK; Hemann MT; Weinstock DM
Cancer Discov; 2019 Jul; 9(7):944-961. PubMed ID: 31040105
[TBL] [Abstract] [Full Text] [Related]
18. B cells in chronic graft-versus-host disease.
McManigle W; Youssef A; Sarantopoulos S
Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
[TBL] [Abstract] [Full Text] [Related]
19. bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
Wang D; Liu P; Zhang Y; Liu HY; Shen D; Che YQ
Biomed Res Int; 2018; 2018():1042597. PubMed ID: 30534553
[TBL] [Abstract] [Full Text] [Related]
20. Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptors.
Luo Q; Wei G; Wu X; Tang K; Xu M; Wu Y; Liu Y; Li X; Sun Z; Ju W; Qi K; Chen C; Yan Z; Cheng H; Zhu F; Li Z; Zeng L; Xu K; Qiao J
J Transl Med; 2018 Nov; 16(1):311. PubMed ID: 30442147
[TBL] [Abstract] [Full Text] [Related]
[Next]